Skip to main content
. 2022 Sep 20;7(39):35077–35082. doi: 10.1021/acsomega.2c03963

Table 2. Cytotoxic Activities (% of Inhibition) of the Extract, Natural Products, and Derivativesa.

sample U251 PC-3 K562 HCT-15 MCF-7 SKLU-1 COS7
CH2Cl2/CH3OH 1:1 (leaves extract) 52.31 43.6 74.63 34.5 62.45 58.35 NP
(1) 59.8 87.2 100 74.6 61.4 88.4 22.0
euphol (2) NA NA 26.9 2.18 36.62 4.9 NA
lupeol (5) 27.3 50.7 48.8 10.4 22.3 13.0 NP
(6) NA NA 33.1 15.6 1.3 10.9 NA
(7) NA NA 39.8 39.4 20.1 40.0 NA
(8) NA NA 95.0 12.2 1.5 31.3 17.2
(10) NA NA 57.8 4.3 4.3 21.6 NA
(12) NA NA 34.1 16.4 NA 4.6 NA
etoposideb 91.1c 51.4d 60.2d 80.8d 56.8d 81.7d NP

NA: no activity; ND: not determined. Human tumor cell lines: U251 (glioblastoma), PC-3 (prostate), K562 (leukemia), HCT-15 (colon), MCF-7 (breast), and SKLU-1 (lung). COS7: noncancerous cell line of monkey kidney.

a

Concentrations: 50 μg/mL for the extract, 50 μM for pure compounds, DMSO vehicle.

b

Positive control.

c

Concentration at 10 μM.

d

Concentration at 31 μM.